Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-250.14	-211.23	-203.51	-325.73
Depreciation & Amortization	33.96	35.67	31.3	30.84
Other Amortization	0.62	0.57	0.48	0.75
Loss (Gain) From Sale of Assets	-	-0.04	-	0.08
Stock-Based Compensation	11.84	23.91	21.28	32.7
Other Operating Activities	-106.25	-90.5	-52.53	7.56
Change in Accounts Receivable	-23.88	372.75	-413.24	-13.62
Change in Inventory	-82.04	-42.72	-1.9	-
Change in Accounts Payable	2.88	38.27	-0.01	-2.51
Change in Unearned Revenue	-	756.99	366.53	-
Change in Other Net Operating Assets	-4.96	5.7	21.48	-3.03
Operating Cash Flow	-417.97	889.37	-230.11	-272.98
Capital Expenditures	-2.83	-9.74	-4.56	-20.2
Sale of Property, Plant & Equipment	-	0.07	-	0.07
Cash Acquisitions	-	-	-0.71	-
Sale (Purchase) of Intangibles	-1.03	-0.1	-22.91	-6.39
Other Investing Activities	13.9	17.85	23.42	-41.71
Investing Cash Flow	10.04	8.08	-4.75	-68.22
Long-Term Debt Issued	133.15	200	28.92	-
Long-Term Debt Repaid	-44.26	-135.74	-18.36	-16.48
Total Debt Repaid	-44.26	-135.74	-18.36	-16.48
Net Debt Issued (Repaid)	88.89	64.26	10.56	-16.48
Issuance of Common Stock	1.61	9.89	11	10.35
Other Financing Activities	-6.78	-5.08	-0.09	-
Financing Cash Flow	83.72	69.07	21.48	-6.13
Foreign Exchange Rate Adjustments	3.13	3.68	28.78	-9.52
Net Cash Flow	-321.07	970.19	-184.61	-356.85
Free Cash Flow	-420.8	879.63	-234.67	-293.18
Free Cash Flow Margin	-164.44%	1148.19%	-1333.44%	-
Free Cash Flow Per Share	-0.43	0.90	-0.24	-0.31
Cash Interest Paid	6.78	5.08	0.09	-
Levered Free Cash Flow	-268.93	249.64	-524.53	-183.45
Unlevered Free Cash Flow	-263.55	254.58	-522.24	-180.98
Change in Working Capital	-107.99	1,131	-27.13	-19.17

Source: S&P Global Market Intelligence. Standard template. Financial Sources.